R
Ramsin M Benyamin
Researcher at University of Illinois at Urbana–Champaign
Publications - 174
Citations - 13782
Ramsin M Benyamin is an academic researcher from University of Illinois at Urbana–Champaign. The author has contributed to research in topics: Randomized controlled trial & Lumbar. The author has an hindex of 59, co-authored 168 publications receiving 12245 citations. Previous affiliations of Ramsin M Benyamin include University of Illinois at Chicago & Illinois Wesleyan University.
Papers
More filters
Journal ArticleDOI
Opioid complications and side effects.
Ramsin M Benyamin,Andrea M. Trescot,Sukdeb Datta,Ricardo M. Buenaventura,Rajive Adlaka,Nalini Sehgal,Scott E. Glaser,Ricardo Vallejo +7 more
TL;DR: The role of opioids in the treatment of chronic pain is influenced by the fact that these potent analgesics are associated with a significant number of side effects and complications, and these phenomena are the focus of this review.
Journal ArticleDOI
Novel 10-kHz High-frequency Therapy (HF10 Therapy) Is Superior to Traditional Low-frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg Pain: The SENZA-RCT Randomized Controlled Trial.
Leonardo Kapural,Cong Yu,Matthew W. Doust,Bradford E. Gliner,Ricardo Vallejo,B. Todd Sitzman,Kasra Amirdelfan,Donna M. Morgan,Lora L. Brown,Thomas L. Yearwood,Richard Bundschu,Allen W. Burton,Thomas Yang,Ramsin M Benyamin,Abram H. Burgher +14 more
TL;DR: HF10 therapy promises to substantially impact the management of back and leg pain with broad applicability to patients, physicians, and payers.
Journal Article
Interventional Techniques: Evidence-based Practice Guidelines in the Management of Chronic Spinal Pain
Mark V. Boswell,Andrea M. Trescot,Sukdeb Datta,Sukdeb Datta,David M. Schultz,Hans Hansen,Salahadin Abdi,Nalini Sehgal,Rinoo V. Shah,Vijay Singh,Ramsin M Benyamin,Vikram B. Patel,Ricardo M. Buenaventura,James D. Colson,Harold Cordner,Richard S. Epter,Joseph F. Jasper,Elmer E. Dunbar,Sairam Atluri,Richard C. Bowman,Timothy R. Deer,John R. Swicegood,Peter S. Staats,Howard S. Smith,Allen W. Burton,David Kloth,James Giordano,Laxmaiah Manchikanti +27 more
TL;DR: These guidelines include the evaluation of evidence for diagnostic and therapeutic treatment recommendations for chronic spinal pain, and the accuracy of facet joint nerve blocks is strong in the diagnosis of lumbar and cervical facet joint pain, whereas, it is moderate in the Diagnostic Accuracy Studies.
Journal Article
American Society of Interventional Pain Physicians (ASIPP) Guidelines for Responsible Opioid Prescribing in Chronic Non-Cancer Pain: Part 2 - Guidance
Laxmaiah Manchikanti,Salahadin Abdi,Sairam Atluri,Carl C. Balog,Ramsin M Benyamin,Mark V. Boswell,Keith R. Brown,Brian Mendoza Bruel,David A. Bryce,Patricia A. Burks,Allen W. Burton,Aaron K. Calodney,David Caraway,Kimberly A Cash,Paul J. Christo,Kim S Damron,Sukdeb Datta,Timothy R. Deer,Sudhir Diwan,Ike Eriator,Frank J E Falco,Bert Fellows,Stephanie Geffert,Christopher Gharibo,Scott E. Glaser,Jay S. Grider,Haroon Hameed,Mariam Hameed,Hans Hansen,Michael E. Harned,Salim M. Hayek,Standiford Helm,Joshua A Hirsch,Jeffrey W. Janata,Alan D. Kaye,Adam M. Kaye,David Kloth,Dhanalakshmi Koyyalagunta,Marion Lee,Yogesh Malla,Kavita N. Manchikanti,Carla D McManus,Vidyasagar Pampati,Allan T. Parr,Ramarao Pasupuleti,Vikram B. Patel,Nalini Sehgal,Sanford M. Silverman,Vijay P. Singh,Howard S. Smith,Lee T. Snook,Daneshvari R. Solanki,Deborah H. Tracy,Ricardo Vallejo,Bradley W. Wargo +54 more
TL;DR: A robust agreement which is followed by all parties is essential in initiating and maintaining opioid therapy as such agreements reduce overuse, misuse, abuse, and diversion.
Journal Article
Opioids in the management of chronic non-cancer pain
Andrea M. Trescot,Standiford Helm,Hans Hansen,Ramsin M Benyamin,Scott E. Glaser,Rajive Adlaka,Samir P. Patel,Laxmaiah Manchikanti,Sukdeb Datta,Nalini Sehgal,James D. Colson,Art Jordan,Marion Lee +12 more
TL;DR: The evidence for the effectiveness of long-term opioids in reducing pain and improving functional status for 6 months or longer is variable and the recommendation is 2A - weak recommendation, high-quality evidence: with benefits closely balanced with risks and burdens.